InsiderCow.com: C Rajesh. Shrotriya MD of Spectrum Pharmaceuticals, Inc.(NasdaqGM: SPPI) bought Shares of SPPI

Reported by InsiderCow.com at 2009-10-16 13:52:52 ET

C RAJESH. SHROTRIYA MD, CEO of Spectrum Pharmaceuticals, Inc.(NasdaqGM: SPPI) bought 10,000 shares of SPPI from the open market on 2009-10-16. The stock was up 8.18% after the InsiderCow.com report.

Trade amount: 10,000 Shares

Trade type: Open Market Buy

Price Range: $4.57 - $4.58

Transaction details can be found at http://www.insidercow.com/history/company.jsp?company=SPPI. You can also get real-time alert on any insider trading information from www.insidercow.com, one step before everybody else.

About InsiderCow.com

InsiderCow.com is a leading real-time insider trading information provider. InsiderCow.com is the online division of InsiderCow, a privately-owned company specialized in insider trading information. InsiderCow uses its proprietary software to gather and analyze information provided by the U.S. Securities and Exchange Commission, in real-time. For more information about InsiderCow.com, visit www.insidercow.com.

About SPPI

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a focus on oncology, develops and commercializes a portfolio of drug products. Its marketed products include ZEVALIN, a form of cancer therapy called radioimmunotherapy for the treatment of non-Hodgkin's Lymphoma (NHL); and FUSILEV, which is indicated after high-dose methotrexate therapy in patients with osteosarcoma.

CONTACT: InsiderCow.com e-mail: support@insidercow.com WWW: http://www.insidercow.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: biotechnology, cancer, ceo, commercial, e-mail, insider trading, investment opinion, market, nhl, pharmaceuticals, products, securities, software, trade, web